The Global Microplastics Regulatory Landscape in 2026: Active but Fragmented

For decades, plastic pollution was something we could see - bottles floating in oceans, bags tangled in trees, debris lining shorelines. Then the narrative shifted. Scientists began detecting something far more elusive: micro- and nanoplastics (MNPs), particles smaller than five millimeters, embedded not just in marine ecosystems, but in soil, air, food, and even human tissue. What started as a marine litter problem has evolved into a diffuse, almost invisible form of contamination.

Although researchers across disciplines are working to understand how these particles move through ecosystems and their implications for long-term environmental and human health, the science is still catching up to the scale of the problem. (Read the first article in our series: Too Small to See, Too Big to Ignore: The World Wrestles With a Plastic Problem.)

Everywhere and All Around Us

Microplastics come from a wide range of sources: the slow breakdown of larger plastics, the shedding of synthetic clothing, the erosion of tires on roadways. They drift through the atmosphere, settle in agricultural soils, and enter waterways in ways that are difficult to trace and even harder to measure. One of the biggest challenges researchers face is simply defining the problem consistently. There are still no universally accepted standards for sampling or quantifying microplastics, and the emerging category of nanoplastics complicates things further. This scientific uncertainty has created a paradox: growing evidence of widespread exposure, but limited clarity on the actual risks.

For chemical manufacturers, formulators, and distributors operating across multiple jurisdictions, the cumulative regulatory picture in 2026 is unprecedented in its complexity and compliance demands. The European Union's (EU) REACH Restriction 78 (Commission Regulation (EU) 2023/2055 on the Registration, Evaluation, Authorization, and Restriction of Chemicals as Regards Synthetic Polymer Microparticles) alone requires precise tracking, labeling, safety data sheet (SDS) updates, and emissions reporting. In North America, the federal government has been slow to act on MNPs, so individual states have been addressing the issue. Meanwhile, in Asia, Japan - one of the world's largest plastic consumers per capita - has pledged to play a leading role in tackling the crisis, while it remains an emerging issue for other jurisdictions in the region.

For companies with large product portfolios, this means managing hundreds of formulations, ensuring accuracy in multiple languages, and keeping pace with evolving guidance from the European Chemicals Agency (ECHA), the U.S. Environmental Protection Agency (EPA), and other agencies. Manufacturers not doing business in the regions where MNP standards and regulations are being developed are not insulated: While the legal obligation to report falls on the importer in that region or the company that has placed the products on the market, they cannot fulfill their reporting duties without precise data from their global suppliers. This means companies operating in that region and their suppliers must provide details on polymer identity, concentration, and safe-use instructions to ensure their customers remain in compliance.

Beyond meeting regulatory compliance requirements, the chemical industry faces a deeper strategic challenge rooted in public perception. The American Chemistry Council has encouraged additional research to fill informational gaps to help lawmakers make fact-based decisions. The industry seems aware that the gap between scientific uncertainty and public concern is narrowing faster than regulatory frameworks can accommodate.

Litigation is accelerating the timeline, with U.S. state attorneys general and plaintiffs' lawyers suing product manufacturers, accusing them of making false or misleading statements regarding microplastics, and some courts have allowed claims to proceed past the motion-to-dismiss stage.

In a microplastics litigation update published in 2025, attorneys Monty Cooper, a partner at Crowell, and Eryn Howington, an associate at Crowell, suggested that their clients track scientific developments to evaluate litigation risks. “As states, like Michigan, consider conducting research to better understand microplastics' human health impacts, the scientific community will continue investigating this issue. If future research establishes a causal link, plaintiffs will likely bring personal-injury claims, significantly increasing litigation risks for plastics manufacturers and users. Thus, manufacturers should follow the scientific research in this area,” wrote Cooper and Howington.

The convergence of REACH reporting deadlines, California's Candidate Chemicals List proposal, expanding country and state-level restrictions, and growing litigation exposure means that for the global chemical industry, microplastics is no longer a future risk to monitor - it is a present compliance and reputational challenge to manage.

Regulatory Action Gains Traction

Regulatory momentum is building, but it remains ahead of the science in some areas and behind it in others. In 2025, regulatory measures in the United States at both state and federal levels were introduced with increasing frequency. Some claim that limited health impact studies and gaps in information mean that existing microplastics data are often insufficient to make scientifically sound and fact-based regulatory decisions.

“What we're seeing is a widening regulatory gap,” acknowledges Cassidy Spencer, the materials and sustainability regulatory manager for 3E. “The EU has already implemented a sweeping restriction on intentionally added microplastics under REACH, with deadlines, reporting requirements, and reformulation pressures that are actively reshaping the chemicals market. Meanwhile, in the U.S., the conversation is still largely exploratory, focusing on studies, proposed legislation, and a patchwork of state-level measures. For industry, that means compliance is being driven by Europe, not by a global consensus.”

Regulators have not waited for definitive answers from researchers, but their differing approaches reflect the uncertainty that remains around MNLs. At the global level, momentum is building around a legally binding plastics agreement led by the United Nations Environment Programme, an effort that aims to address plastics across their entire life cycle. Yet consensus remains elusive, particularly when it comes to limiting production versus managing waste. In the meantime, regional leaders are moving ahead. The European Union has taken some of the most aggressive measures, including restrictions on intentionally added microplastics and a growing focus on less visible sources like textiles and industrial pellets. In contrast, the United States is advancing more cautiously, emphasizing research and risk assessment before implementing broad regulatory controls.

What's becoming clear is that the regulatory lens is widening. Early policies targeted obvious offenders - microbeads in cosmetics and single-use plastics - but the next wave is tackling systemic sources that are deeply embedded in modern economies. That means looking upstream at material design, midstream at product use, and downstream at waste and environmental release. It also means new expectations for data: Companies may soon need to measure, disclose, and ultimately reduce their microplastic footprint across complex supply chains. In this way, microplastics are evolving from a niche environmental concern into a cross-sector accountability issue.

The story of microplastics is still being written, but its trajectory is clear. Science is accelerating, regulation is expanding, litigation continues, and industry is beginning to respond with new materials, filtration technologies, and design strategies. The tipping point will likely come when scientific evidence on human health catches up with environmental findings. When that happens, microplastics will no longer be treated as an emerging issue; they will become a defining challenge of how we produce, use, and manage materials in a world increasingly shaped by the unintended consequences of its own innovations.

Be on the lookout for the next article in our Microplastics 2026 series:

From Microbeads to Macro-Regulation: The EU Framework Everyone Is Watching

Micro and nanoplastics (MNPs) have quietly moved from an emerging scientific concern to a full-scale regulatory priority across the EU. Defined as plastic particles smaller than five millimeters, these materials are now found everywhere - from oceans and soil to food and drinking water and even, it seems, in our bodies. The latest scientific research raises persistent questions about long-term ecological and human health impacts. While the U.S. debates study mandates, the EU is already deep into implementation.